Published in J Clin Invest on December 15, 1996
Neonatal β cell development in mice and humans is regulated by calcineurin/NFAT. Dev Cell (2012) 1.72
Proinflammatory cytokines activate the intrinsic apoptotic pathway in beta-cells. Diabetes (2009) 1.60
Clinical and experimental pancreatic islet transplantation to striated muscle: establishment of a vascular system similar to that in native islets. Diabetes (2010) 1.20
Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells. Br J Pharmacol (2011) 1.01
Pancreatic β-cell dysfunction and risk of new-onset diabetes after kidney transplantation. Diabetes Care (2013) 1.00
Novel views on new-onset diabetes after transplantation: development, prevention and treatment. Nephrol Dial Transplant (2013) 0.97
Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes. Transplantation (2008) 0.97
Evolving insights regarding mechanisms for the inhibition of insulin release by norepinephrine and heterotrimeric G proteins. Am J Physiol Cell Physiol (2012) 0.90
The role of serine/threonine protein phosphatases in exocytosis. Biochem J (2003) 0.89
Transgenic overexpression of active calcineurin in beta-cells results in decreased beta-cell mass and hyperglycemia. PLoS One (2010) 0.89
Calcineurin inhibition and new-onset diabetes mellitus after transplantation. Transplantation (2013) 0.87
Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation. J Transplant (2011) 0.85
Deregulation of CREB signaling pathway induced by chronic hyperglycemia downregulates NeuroD transcription. PLoS One (2012) 0.84
Long-term results of pancreas transplantation under tacrolius immunosuppression. Transplantation (1999) 0.80
Regulation of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus at concentrations that inhibit calcineurin activity and involving the transcription factor CREB. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.80
Extracellular factors and immunosuppressive drugs influencing insulin secretion of murine islets. Clin Exp Immunol (2012) 0.77
Protein phosphatases in pancreatic islets. J Endocrinol (2014) 0.77
Implication of mitochondrial cytoprotection in human islet isolation and transplantation. Biochem Res Int (2012) 0.77
Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes. Endocr Rev (2015) 0.76
New-Onset Diabetes Mellitus After Transplantation in a Cynomolgus Macaque (Macaca fasicularis). Comp Med (2015) 0.76
Prediabetes in Pediatric Recipients of Liver Transplant: Mechanism and Risk Factors. J Pediatr (2016) 0.75
Management of the hospitalized transplant patient. Curr Diab Rep (2015) 0.75
Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients. Int J Nephrol Renovasc Dis (2010) 0.75
Post-renal transplant diabetes mellitus in korean subjects: superimposition of transplant-related immunosuppressant factors on genetic and type 2 diabetic risk factors. Diabetes Metab J (2012) 0.75
Beneficial effects of mycophenolate mofetil on cardiotoxicity induced by tacrolimus in wistar rats. Exp Biol Med (Maywood) (2016) 0.75
Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res (1989) 22.73
Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science (1991) 6.80
FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature (1992) 5.75
Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31
Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation. J Immunol (1987) 3.30
Insulin synthesis in a clonal cell line of simian virus 40-transformed hamster pancreatic beta cells. Proc Natl Acad Sci U S A (1981) 2.96
Control of insulin gene expression in pancreatic beta-cells and in an insulin-producing cell line, RIN-5F cells. II. Regulation of insulin mRNA stability. J Biol Chem (1985) 2.09
Control of insulin gene expression in pancreatic beta-cells and in an insulin-producing cell line, RIN-5F cells. I. Effects of glucose and cyclic AMP on the transcription of insulin mRNA. J Biol Chem (1985) 1.95
Regulation of insulin gene expression by glucose and calcium in transfected primary islet cultures. J Biol Chem (1990) 1.81
Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcription and alters binding of insulin gene regulatory protein. J Clin Invest (1993) 1.81
FK506 and cyclosporin, molecular probes for studying intracellular signal transduction. Immunol Today (1993) 1.56
New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc (1991) 1.56
Insulin biosynthesis. I. On the mechanism of glucose stimulation. J Biol Chem (1972) 1.54
The reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to high glucose concentration is associated with the loss of RIPE3b1 and STF-1 transcription factor expression. Mol Endocrinol (1995) 1.52
Reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to a supraphysiologic glucose concentration is associated with loss of STF-1 transcription factor expression. Proc Natl Acad Sci U S A (1995) 1.45
Adverse effects associated with the use of FK 506. Transplant Proc (1991) 1.41
Direct effect of glucose on the preproinsulin mRNA level in isolated pancreatic islets. Biochem Biophys Res Commun (1982) 1.37
Sequences within the 5'-flanking region of the S14 gene confer responsiveness to glucose in primary hepatocytes. J Biol Chem (1989) 1.27
Control of insulin gene expression by glucose. Biochem J (1992) 1.23
Glucose induces insulin gene transcription in a murine pancreatic beta-cell line. J Biol Chem (1991) 1.19
Clinical trial of FK 506 immunosuppression in adult cardiac transplantation. Ann Thorac Surg (1992) 1.18
Effect of the immunosuppressant FK506 on glucose-induced insulin secretion from adult rat islets of Langerhans. Transplantation (1991) 1.13
Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell. Transplantation (1995) 1.10
Roles of calmodulin-dependent protein kinases and phosphatase in calcium-dependent transcription of immediate early genes. J Biol Chem (1994) 1.03
Structure and pancreatic expression of the insulin and glucagon genes. Endocr Rev (1991) 0.96
G-proteins and hormonal inhibition of insulin secretion from HIT-T15 cells and isolated rat islets. Diabetes (1992) 0.95
Inhibition of cAMP-responsive element-mediated gene transcription by cyclosporin A and FK506 after membrane depolarization. J Biol Chem (1993) 0.94
Regulation of human insulin gene transcription by glucose, epinephrine, and somatostatin. Diabetes (1994) 0.91
Inhibition of glucose-stimulated insulin release from beta TC3 cells and rodent islets by an analog of FK506. Transplantation (1993) 0.87
Metabolic effects of cyclosporin A and FK 506 in liver transplant recipients. Diabetes (1993) 0.86
Regulation of insulin gene expression by dexamethasone, Ca2+ and a phorbol ester. Biomed Biochim Acta (1988) 0.85
Morphological and functional changes of islets of Langerhans in FK506-treated rats. Transplantation (1992) 0.85
Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression. Transplant Proc (1993) 0.85
Somatostatin and epinephrine decrease insulin messenger ribonucleic acid in HIT cells through a pertussis toxin-sensitive mechanism. Endocrinology (1991) 0.85
Metabolic control of insulin gene expression and biosynthesis. Proc Nutr Soc (1991) 0.84
Identification of the calmodulin-regulated protein phosphatase, calcineurin, in rat pancreatic islets. Biochim Biophys Acta (1991) 0.84
Transcription of the insulin gene: towards defining the glucose-sensitive cis-element and trans-acting factors. Diabetologia (1994) 0.82
Effect of FK506 on insulin secretion in normal dogs. Metabolism (1992) 0.82
Effect of FK 506 on glucose metabolism and insulin secretion in normal rats. Transplant Proc (1991) 0.82
Inhibition of insulin release by FK 506 and its prevention by rioprostil, a stable prostaglandin E1 analogue. Transplant Proc (1991) 0.82
Calmodulin can modulate protein phosphorylation in rat liver cells nuclei. J Biol Chem (1993) 0.81
Galanin inhibits proinsulin gene expression stimulated by the insulinotropic hormone glucagon-like peptide-I(7-37) in mouse insulinoma beta TC-1 cells. Endocrinology (1992) 0.80
Specific disruption of renal function and gene transcription by cyclosporin A. J Biol Chem (1992) 0.80
Variable regulation by insulin of insulin gene expression in HIT-T15 cells. Diabetologia (1994) 0.77
Somatostatin inhibits insulin-gene expression through a posttranscriptional mechanism in a hamster islet cell line. Diabetes (1993) 0.77
Evaluation of chloramphenicol and ampicillin in salmonella enteric fever. N Engl J Med (1968) 2.41
Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab (1976) 2.39
Endobronchial metastases due to colorectal carcinoma. Chest (1989) 2.13
Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci U S A (1999) 1.94
Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89
Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Ann Intern Med (1999) 1.81
Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcription and alters binding of insulin gene regulatory protein. J Clin Invest (1993) 1.81
Preserved insulin secretion and insulin independence in recipients of islet autografts. N Engl J Med (1992) 1.74
Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med (1990) 1.53
The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor. J Clin Invest (1973) 1.53
The reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to high glucose concentration is associated with the loss of RIPE3b1 and STF-1 transcription factor expression. Mol Endocrinol (1995) 1.52
Rotation of the anatomic regions used for insulin injections and day-to-day variability of plasma glucose in type I diabetic subjects. JAMA (1990) 1.50
Insulin secretion and cAMP metabolism in HIT cells. Reciprocal and serial passage-dependent relationships. Diabetes (1989) 1.38
Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann Surg (1995) 1.37
Adrenergic modulation of basal insulin secretion in man. Diabetes (1973) 1.29
Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass. Diabetes (1998) 1.29
Chronic exposure of betaTC-6 cells to supraphysiologic concentrations of glucose decreases binding of the RIPE3b1 insulin gene transcription activator. J Clin Invest (1996) 1.28
Control of insulin secretion by catecholamines, stress, and the sympathetic nervous system. Fed Proc (1973) 1.28
Pancreatic endocrine function in cystic fibrosis. J Pediatr (1991) 1.28
Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts. J Clin Invest (1990) 1.26
Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene. Diabetes (1994) 1.24
Effects of hemipancreatectomy on pancreatic alpha and beta cell function in healthy human donors. J Clin Invest (1992) 1.20
A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus. J Clin Invest (1976) 1.19
Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients. Diabetes (1990) 1.17
DNA fragmentation in targets of CTL: an example of programmed cell death in the immune system. Adv Exp Med Biol (1985) 1.16
Lipoxygenase pathway in islet endocrine cells. Oxidative metabolism of arachidonic acid promotes insulin release. J Clin Invest (1983) 1.16
Insulin-secreting cell lines: classification, characteristics and potential applications. Diabetes Metab (1996) 1.15
A role for prostaglandin E in defective insulin secretion and carbohydrate intolerance in diabetes mellitus. J Clin Invest (1977) 1.14
Receptor-mediated adenylate cyclase-coupled mechanism for PGE2 inhibition of insulin secretion in HIT cells. Diabetes (1987) 1.13
Determinants of glucose toxicity and its reversibility in the pancreatic islet beta-cell line, HIT-T15. Am J Physiol Endocrinol Metab (2000) 1.13
Antecedent hyperglycemia, not hyperlipidemia, is associated with increased islet triacylglycerol content and decreased insulin gene mRNA level in Zucker diabetic fatty rats. Diabetes (2001) 1.09
The GENNID Study. A resource for mapping the genes that cause NIDDM. Diabetes Care (1996) 1.08
Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet. Proc Natl Acad Sci U S A (1998) 1.06
Real-time breast sonography: application in 300 consecutive patients. AJR Am J Roentgenol (1986) 1.06
Paratyphoid A fever. Ann Intern Med (1969) 1.06
Iron and diabetes: an attractive hypothesis, but... Mayo Clin Proc (1994) 1.05
Computed tomography in the diagnosis of traumatic rupture of the thoracic aorta. Clin Radiol (1989) 1.04
Prostaglandin E-induced heterologous desensitization of hepatic adenylate cyclase. Consequences on the guanyl nucleotide regulatory complex. J Biol Chem (1983) 1.04
Prostaglandin E(2) mediates inhibition of insulin secretion by interleukin-1beta. J Biol Chem (1999) 1.03
Cyclosporin-induced inhibition of insulin secretion in isolated rat islets and HIT cells. Diabetes (1986) 1.03
Characterization and regulation of prostaglandin and leukotriene receptors: an overview. Prostaglandins (1986) 1.02
Upstream stimulatory factor regulates Pdx-1 gene expression in differentiated pancreatic beta-cells. Biochem J (1999) 1.01
Fluid absorption during transurethral resection. Br Med J (1980) 1.00
Hyperproinsulinemia is associated with increased beta cell demand after hemipancreatectomy in humans. J Clin Invest (1996) 1.00
Inhibition of in vivo insulin secretion by prostaglandin E1. J Clin Invest (1974) 0.99
Suppression of adenylate kinase catalyzed phosphotransfer precedes and is associated with glucose-induced insulin secretion in intact HIT-T15 cells. J Biol Chem (1996) 0.99
Pancreas transplantation restores epinephrine response and symptom recognition during hypoglycemia in patients with long-standing type I diabetes and autonomic neuropathy. Diabetes (1997) 0.99
In vivo prevention of hyperglycemia also prevents glucotoxic effects on PDX-1 and insulin gene expression. Diabetes (1999) 0.99
Defective glucagon secretion during sustained hypoglycemia following successful islet allo- and autotransplantation in humans. Diabetes (1997) 0.99
Differentiation of glucose toxicity from beta cell exhaustion during the evolution of defective insulin gene expression in the pancreatic islet cell line, HIT-T15. J Clin Invest (1997) 0.98
Potentiation of glucocorticoid receptor-mediated gene expression by heat and chemical shock. Mol Endocrinol (1994) 0.98
The defective glucagon response from transplanted intrahepatic pancreatic islets during hypoglycemia is transplantation site-determined. Diabetes (1997) 0.97
Reconstitution of glucotoxic HIT-T15 cells with somatostatin transcription factor-1 partially restores insulin promoter activity. Diabetes (1998) 0.97
Pertussis toxin-sensitive G protein mediation of PGE2 inhibition of cAMP metabolism and phasic glucose-induced insulin secretion in HIT cells. Diabetes (1989) 0.96
Morphological and functional characterization of beta TC-6 cells--an insulin-secreting cell line derived from transgenic mice. Diabetes (1995) 0.96
Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets. Transplantation (2002) 0.96
Successful islet transplantation for patients with diabetes--fact or fantasy? N Engl J Med (2000) 0.96
Chloramphenicol-induced hemolysis in Caucasian glucose-6-phosphate dehydrogenase deficiency. Ann Intern Med (1971) 0.96
Defective glucagon secretion during hypoglycemia after intrahepatic but not nonhepatic islet autotransplantation. Am J Transplant (2014) 0.95
Metabolic syndrome: psychosocial, neuroendocrine, and classical risk factors in type 2 diabetes. Ann N Y Acad Sci (2007) 0.95
G-proteins and hormonal inhibition of insulin secretion from HIT-T15 cells and isolated rat islets. Diabetes (1992) 0.95
Sounding board. Prostaglandins, the glucoreceptor, and diabetes. N Engl J Med (1979) 0.95
Plasma catecholamine responses to intravenous glucose in normal man. J Clin Endocrinol Metab (1974) 0.95
Restoration of the acute insulin response by sodium salicylate. A glucose dose-related phenomenon. Diabetes (1978) 0.95
Restored hypoglycemic counterregulation is stable in successful pancreas transplant recipients for up to 19 years after transplantation. Transplantation (2001) 0.94
Effects of prostaglandin synthesis inhibitors on human insulin secretion and carbohydrates tolerance. Prostaglandins (1979) 0.94
Differentiation between glucose-induced desensitization of insulin secretion and beta-cell exhaustion in the HIT-T15 cell line. Diabetes (1998) 0.93
Paradoxical inhibition of insulin secretion by glucose in human diabetes mellitus. J Clin Endocrinol Metab (1979) 0.93
Plasma prostaglandin E in patients with cancer with and without hypercalcemia. J Clin Endocrinol Metab (1976) 0.92
Induction of defective insulin secretion and impaired glucose tolerance by clonidine. Selective stimulation of metabolic alpha-adrenergic pathways. Diabetes (1978) 0.92
Prostaglandins as mediators of paraneoplastic syndromes: review and up-date. Metabolism (1981) 0.92
Lipoxygenation of arachidonic acid: a pivotal step in stimulus-secretion coupling in the pancreatic beta cell. Endocrinology (1982) 0.91
Beta cell nuclear musculoaponeurotic fibrosarcoma oncogene family A (MafA) is deficient in type 2 diabetes. Diabetologia (2012) 0.91
Increased expression of GPI-specific phospholipase D in mouse models of type 1 diabetes. Am J Physiol Endocrinol Metab (2001) 0.91
Inhibition of glucagon-stimulated hepatic glycogenolysis by E-series prostaglandins. FEBS Lett (1984) 0.91
Regulation of human insulin gene transcription by glucose, epinephrine, and somatostatin. Diabetes (1994) 0.91
Metabolic assessment prior to total pancreatectomy and islet autotransplant: utility, limitations and potential. Am J Transplant (2013) 0.90
Prostaglandins, glucose homeostasis, and diabetes mellitus. Annu Rev Med (1983) 0.90
Arachidonic acid metabolite regulation of insulin secretion. Diabetes Metab Rev (1986) 0.90
Mouse glycosylphosphatidylinositol-specific phospholipase D (Gpld1) characterization. Mamm Genome (1998) 0.90
AIDS-related spontaneous pneumothorax. Risk factors and treatment. Chest (1995) 0.89
Inhibition of prostaglandin E synthesis augments glucose-induced insulin secretion is cultured pancreas. Diabetes (1981) 0.89
Prostaglandin: increased production by renal cell carcinoma. J Urol (1977) 0.88
Increase in Gs and cyclic AMP generation in HIT cells. Evidence that the 45-kDa alpha-subunit of Gs has greater functional activity than the 52-kDa alpha-subunit. J Biol Chem (1989) 0.88
An integrated view of beta-cell dysfunction in type-II diabetes. Annu Rev Med (1996) 0.88
High levels of the circulating form of parathyroid hormone do not inhibit in vitro erythropoiesis. J Lab Clin Med (1983) 0.88
Diminished insulin secretory reserve in diabetic pancreas transplant and nondiabetic kidney transplant recipients. Diabetes (1994) 0.87
Elevated prostaglandins and suppressed parathyroid hormone associated with hypercalcemia and renal cell carcinoma. J Clin Endocrinol Metab (1975) 0.87
Kinetics of prostaglandin E metabolism in isolated hepatocytes. Biochim Biophys Acta (1984) 0.87
Transfection with SV40 gene of human pancreatic endocrine cells. J Autoimmun (1991) 0.87
Hypothesis. PGE, carbohydrate homeostasis, and insulin secretion. A suggested resolution of the controversy. Diabetes (1983) 0.86
Paradoxical hypoinsulinaemia: an alpha-adrenergic-mediated response to glucose. Lancet (1972) 0.86